Research & Development
Academic Report
Correlation between Soluble Checkpoint Molecules and Disease Activity in Autoimmune Diseases
| Presented by: | Kosaku Murakami1), Akiko Yoshida1), Hitoshi Uga2), Shuji Sumitomo3), Koichiro Ohmura3), Ryosuke Hiwa4), Tomohiro Kozuki5), Mao Kuroishi2), Chihiro Suminaka2), Mirei Shirakashi4), Hideaki Tsuji4), Shuji Akizuki4), Ran Nakashima4), Hajime Yoshifuji4), Akira Onishi6), Masao Tanaka6), Akio Morinobu4), Kenji Chamoto5), Tasuku Honjo5) |
| 1) Division of Clinical Immunology and Cancer Immunotherapy, Center for Cancer Immunotherapy and Immunobiology, Graduate School of Medicine, Kyoto University 2) Central Research Laboratories, Sysmex Corporation 3) Kobe City Medical Center General Hospital 4) Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University 5) Department of Immunology and Genomic Medicine, Center for Cancer Immunotherapy and Immunobiology, Graduate School of Medicine, Kyoto University 6) Department of Advanced Medicine for Rheumatic Diseases, Graduate School of Medicine, Kyoto University |
|
| Academic conference: |
ACR Convergence 2025（ACR: American College of Rheumatology） |
| Presentation Date: | October 28, 2025 |
- Information contained in the academic report is current as of the date of the announcement,
but may be subject to change without prior notice.